Sergio Di Molfetta

669 total citations
38 papers, 371 citations indexed

About

Sergio Di Molfetta is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Sergio Di Molfetta has authored 38 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 12 papers in Genetics. Recurrent topics in Sergio Di Molfetta's work include Diabetes Management and Research (22 papers), Diabetes Treatment and Management (14 papers) and Diabetes and associated disorders (12 papers). Sergio Di Molfetta is often cited by papers focused on Diabetes Management and Research (22 papers), Diabetes Treatment and Management (14 papers) and Diabetes and associated disorders (12 papers). Sergio Di Molfetta collaborates with scholars based in Italy, United States and Australia. Sergio Di Molfetta's co-authors include Francesco Giorgino, Luigi Laviola, Angelo Cignarelli, Sebastio Perrini, Annalisa Natalicchio, Irene Caruso, Antongiulio Faggiano, Annamaria Colao, Claudia Parisi and Marco Castellana and has published in prestigious journals such as British Journal of Cancer, Nutrients and International Journal of Environmental Research and Public Health.

In The Last Decade

Sergio Di Molfetta

36 papers receiving 365 citations

Peers

Sergio Di Molfetta

EDM

SURGE

GENET

EPIDE

ONCOL

Linda Thurby-Hay United States

Sergio Jansen‐Chaparro Spain

Andrew Drexler United States

М. Б. Анциферов Russia

Ellie S. Strock United States

Maria Alice Neves Bordallo Brazil

Barbara Tartaglino Italy

Bo Berger Sweden

Joo Young Nam South Korea

Francesca Di Candia Italy

Linda Thurby-Hay United States

Sergio Di Molfetta

230 ×1.0

EDM

52 ×0.5

SURGE

100 ×1.1

GENET

42 ×0.8

EPIDE

29 ×0.6

ONCOL

Citations per year, relative to Sergio Di Molfetta Sergio Di Molfetta (= 1×) peers Linda Thurby-Hay

Countries citing papers authored by Sergio Di Molfetta

Since Specialization

Citations

This map shows the geographic impact of Sergio Di Molfetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Di Molfetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Di Molfetta more than expected).

Fields of papers citing papers by Sergio Di Molfetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Di Molfetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Di Molfetta. The network helps show where Sergio Di Molfetta may publish in the future.

Co-authorship network of co-authors of Sergio Di Molfetta

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Di Molfetta. A scholar is included among the top collaborators of Sergio Di Molfetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Di Molfetta. Sergio Di Molfetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molfetta, Sergio Di, Irene Caruso, Paolo Trerotoli, et al.. (2025). Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 28(S1). 3–12.

Molfetta, Sergio Di, Irene Caruso, Gian Pio Sorice, et al.. (2025). Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 28(1). 210–220.

Caruso, Irene, Sergio Di Molfetta, Angelo Cignarelli, et al.. (2025). Effectiveness of GLP ‐ 1RA according to different type 2 diabetes phenotypes: A retrospective study. Diabetes Obesity and Metabolism. 27(11). 6210–6219. 1 indexed citations

Malandrino, Pasqualino, Tiziana Feola, Sergio Di Molfetta, et al.. (2024). Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety. Seminars in Nuclear Medicine. 54(4). 570–580. 3 indexed citations

Molfetta, Sergio Di, Antonio Rossi, Federico Boscari, et al.. (2024). Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion. Diabetes Therapy. 15(11). 2263–2278. 2 indexed citations

Molfetta, Sergio Di, Antonio Rossi, Rosaria Gesuita, et al.. (2024). Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study. Acta Diabetologica. 62(4). 563–573. 4 indexed citations

Caruso, Irene, et al.. (2024). The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. Journal of Endocrinological Investigation. 47(11). 2671–2678. 25 indexed citations

Scavelli, Faustina, et al.. (2024). The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetes. Nutrition Metabolism and Cardiovascular Diseases. 34(10). 2344–2352. 4 indexed citations

Caruso, Irene, Sergio Di Molfetta, Angelo Cignarelli, et al.. (2023). Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis. EClinicalMedicine. 64. 102181–102181. 36 indexed citations

10.

Fanciulli, Giuseppe, Anna La Salvia, Sergio Di Molfetta, et al.. (2023). Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms. Journal of Clinical Medicine. 12(24). 7557–7557. 3 indexed citations

11.

Carnevali, Adriano, Valentina Gatti, Massimo Borelli, et al.. (2023). Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy. Journal of Diabetes Research. 2023. 1–7. 7 indexed citations

12.

Molfetta, Sergio Di, et al.. (2023). A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study. International Journal of Environmental Research and Public Health. 20(5). 3945–3945. 1 indexed citations

13.

Molfetta, Sergio Di, Tiziana Feola, Giuseppe Fanciulli, et al.. (2022). Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?. Journal of Clinical Medicine. 11(4). 1019–1019. 7 indexed citations

14.

Pitocco, Dario, Andrea Laurenzi, L. Tomaselli, et al.. (2022). Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology. Nutrition Metabolism and Cardiovascular Diseases. 32(10). 2392–2398. 9 indexed citations

15.

Molfetta, Sergio Di, Angelo Cignarelli, Renata Paleari, et al.. (2022). A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. Journal of Endocrinological Investigation. 45(9). 1663–1671. 8 indexed citations

16.

Molfetta, Sergio Di, Emanuele Bosi, Antonio Ceriello, et al.. (2021). Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial. Diabetes Research and Clinical Practice. 181. 109070–109070. 8 indexed citations

17.

Fanciulli, Giuseppe, Sergio Di Molfetta, Tullio Florio, et al.. (2020). Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks. Journal of Clinical Medicine. 10(1). 88–88. 20 indexed citations

18.

Ciccone, Marco Matteo, Annapaola Zito, Anna Ciampolillo, et al.. (2014). Pulmonary hypertension and Hashimoto’s thyroiditis: does a relationship exist?. Endocrine. 48(2). 621–628. 4 indexed citations

19.

Calabrese, Carlo, Valeria Marzano, Andrea Urbani, et al.. (2011). Distinct proteomic profiles characterise non-erosive from erosive reflux disease. Alimentary Pharmacology & Therapeutics. 34(8). 982–993. 6 indexed citations

20.

Strillacci, Antonio, Cristiana Griffoni, Maria Chiara Valerii, et al.. (2010). Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. British Journal of Cancer. 103(7). 975–986. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact